Intracavernous Injection of Botox 100 U for Treatment of PDE5Is Inconvenient Patients With ED
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
There is a new emerging concept that Botulinum Toxin Type A may have a potential role in
treatment of erectile dysfunction with a longer duration of action. So, the investigators
opted to perform this study to compare ICI of Botulinum Toxin Type A versus Trimix for
treatment of ED.